Your browser doesn't support javascript.
loading
Efficacy of gefitinib­celecoxib combination therapy in docetaxel­resistant prostate cancer.
Lin, Jian-Zhong; Hameed, Irbaz; Xu, Zhen; Yu, Yang; Ren, Zhi-Yun; Zhu, Jia-Geng.
Afiliação
  • Lin JZ; Department of Urology and Central Laboratory, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu 210019, P.R. China.
  • Hameed I; Department of Cancer Research, Southeast University, Nanjing, Jiangsu 210009, P.R. China.
  • Xu Z; Department of Urology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
  • Yu Y; Department of Cancer Research, The First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China.
  • Ren ZY; Central Laboratory, BenQ Medical Center, Nanjing Medical University, Nanjing, Jiangsu 210019, P.R. China.
  • Zhu JG; Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China.
Oncol Rep ; 40(4): 2242-2250, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30066906

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Taxoides / Celecoxib Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Taxoides / Celecoxib Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article